Lysosomal And Rare Disorders Research And Treatment Center Inc
EIN: 455312680 · Fairfax, VA · NTEE: H80
| Metric | Value |
|---|---|
| Total Revenue | $4.4M |
| Total Expenses | $3.7M |
| Net Assets | $891K |
Is Lysosomal And Rare Disorders Research And Treatment Center Inc Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About Lysosomal And Rare Disorders Research And Treatment Center Inc
Lysosomal And Rare Disorders Research And Treatment Center Inc (EIN: 455312680) is a nonprofit organization based in Fairfax, VA, classified under NTEE code H80. The organization reported total revenue of $4.4M and total assets of $2.4M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Lysosomal And Rare Disorders Research And Treatment Center Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Lysosomal And Rare Disorders Research And Treatment Center Inc is a mid-size nonprofit that has been operating for 5 years, with 8 years of IRS 990 filings on record (2014–2023). Revenue has grown at a compound annual rate of 41.0%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $3.4M |
| Total Expenses | $3.7M |
| Surplus / Deficit | $-325,324 |
| Total Assets | $1.9M |
| Total Liabilities | $961K |
| Net Assets | $891K |
| Operating Margin | -9.7% |
| Debt-to-Asset Ratio | 51.9% |
| Months of Reserves | 6.0 months |
Financial Health Grade: C
In 2023, Lysosomal And Rare Disorders Research And Treatment Center Inc reported a deficit of $325K with expenses exceeding revenue, holds 6.0 months of operating reserves (strong position), has a debt-to-asset ratio of 51.9% (high leverage).
Financial Trends
Over 8 years of filings (2014–2023), Lysosomal And Rare Disorders Research And Treatment Center Inc's revenue has grown at a compound annual growth rate (CAGR) of 41.0%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +11.0% | +48.6% | -13.6% |
| 2022 | +13.3% | +18.2% | +31.1% |
| 2021 | +37.7% | -4.9% | +96.1% |
| 2020 | -1.1% | +14.7% | +65.4% |
| 2019 | +421.4% | +447.5% | +456.5% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1200 |
| IRS Ruling Date | 2021 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for Lysosomal And Rare Disorders Research And Treatment Center Inc has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Lysosomal And Rare Disorders Research And Treatment Center Inc with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $325K, with expenses exceeding revenue.
- Debt-to-asset ratio: 51.9%.
Frequently Asked Questions about Lysosomal And Rare Disorders Research And Treatment Center Inc
Is Lysosomal And Rare Disorders Research And Treatment Center Inc a legitimate charity?
Lysosomal And Rare Disorders Research And Treatment Center Inc (EIN: 455312680) is a registered tax-exempt nonprofit based in Virginia. It has 8 years of IRS 990 filings on record. Total revenue: $4.4M. No red flags identified. Financial health grade: C.
How does Lysosomal And Rare Disorders Research And Treatment Center Inc spend its money?
Lysosomal And Rare Disorders Research And Treatment Center Inc reported $4.4M in total revenue in IRS 990 filings. 8 years of filing data available. Expenses exceeded revenue in the most recent year. Review the full spending breakdown on NonprofitSpending.
Are donations to Lysosomal And Rare Disorders Research And Treatment Center Inc tax-deductible?
Lysosomal And Rare Disorders Research And Treatment Center Inc is registered as a tax-exempt nonprofit (EIN: 455312680). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Where is Lysosomal And Rare Disorders Research And Treatment Center Inc located?
Lysosomal And Rare Disorders Research And Treatment Center Inc is headquartered in Fairfax, Virginia and files with the IRS under EIN 455312680. It is classified under NTEE code H80.
How many years of IRS 990 filings does Lysosomal And Rare Disorders Research And Treatment Center Inc have?
Lysosomal And Rare Disorders Research And Treatment Center Inc has 8 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $4.4M in total revenue.
Filing History
IRS 990 filing history for Lysosomal And Rare Disorders Research And Treatment Center Inc showing financial trends over 8 years of public records:
Over 8 years of IRS 990 filings (2014–2023), Lysosomal And Rare Disorders Research And Treatment Center Inc's revenue has grown by 2100%, moving from $152K to $3.4M. Total assets increased by 1202.2% over the same period, from $142K to $1.9M. Total functional expenses rose by 2231.5%, from $158K to $3.7M. In its most recent filing year (2023), Lysosomal And Rare Disorders Research And Treatment Center Inc reported a deficit of $325K, with expenses exceeding revenue. The organization holds $961K in liabilities against $1.9M in assets (debt-to-asset ratio: 51.9%), resulting in net assets of $891K.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $3.4M | $3.7M | $1.9M | $961K | — | View 990 |
| 2022 | $3.0M | $2.5M | $2.1M | $921K | — | View 990 |
| 2021 | $2.7M | $2.1M | $1.6M | $958K | — | — |
| 2020 | $1.9M | $2.2M | $834K | $740K | — | View 990 |
| 2019 | $2.0M | $1.9M | $504K | $143K | — | — |
| 2016 | $375K | $351K | $91K | $107K | — | View 990 |
| 2015 | $195K | $218K | $208K | $249K | — | View 990 |
| 2014 | $152K | $158K | $142K | $160K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $3.4M, expenses of $3.7M, and assets of $1.9M (revenue +11.0% year-over-year).
- 2022: Revenue of $3.0M, expenses of $2.5M, and assets of $2.1M (revenue +13.3% year-over-year).
- 2021: Revenue of $2.7M, expenses of $2.1M, and assets of $1.6M (revenue +37.7% year-over-year).
- 2020: Revenue of $1.9M, expenses of $2.2M, and assets of $834K (revenue -1.1% year-over-year).
- 2019: Revenue of $2.0M, expenses of $1.9M, and assets of $504K (revenue +421.4% year-over-year).
- 2016: Revenue of $375K, expenses of $351K, and assets of $91K (revenue +92.2% year-over-year).
- 2015: Revenue of $195K, expenses of $218K, and assets of $208K (revenue +28.1% year-over-year).
- 2014: Revenue of $152K, expenses of $158K, and assets of $142K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Lysosomal And Rare Disorders Research And Treatment Center Inc:
Data Sources and Methodology
This transparency report for Lysosomal And Rare Disorders Research And Treatment Center Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.